Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Chemical Peels

Phase 2Small molecule

NNorthwestern University

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Actinic KeratosesNot yet recruiting

Actinic KeratosesPhase 2

Not yet recruiting

Timeline

Expected Milestones

Q4 2027

Phase 2Not yet recruiting

Actinic Keratoses

NCT04429308

Clinical

Trials by Indication[1]

Actinic Keratoses1 trial

PDT Versus the Combination of Jessner's Solution and 35% TCA for Treatment of Actinic Keratoses on Upper Extremities: A Randomized Controlled Split-arm Trial

Not yet recruiting·NNorthwestern University·Phase 2·NCT04429308·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Chemical Peels. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Chemical Peels compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Chemical Peels. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Northwestern University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: NNorthwestern University

Related News